nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketorolac—PTGS1—Selenium Micronutrient Network—EPT1—liver cancer	0.0045	0.0182	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—HMOX1—liver cancer	0.00422	0.0171	CbGpPWpGaD
Ketorolac—PTGS1—Eicosanoid Synthesis—GGT1—liver cancer	0.00395	0.016	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—EPT1—liver cancer	0.00357	0.0145	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—HMOX1—liver cancer	0.00335	0.0136	CbGpPWpGaD
Ketorolac—PTGS2—Eicosanoid Synthesis—GGT1—liver cancer	0.00314	0.0127	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00308	0.0125	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—HPGDS—liver cancer	0.00294	0.0119	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—AHR—liver cancer	0.00285	0.0116	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—UGDH—liver cancer	0.0028	0.0114	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—NFE2L2—liver cancer	0.00278	0.0113	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—PIK3CD—liver cancer	0.00257	0.0104	CbGpPWpGaD
Ketorolac—PTGS2—S1P1 pathway—KDR—liver cancer	0.00252	0.0102	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—liver cancer	0.00249	0.0101	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—EFNB2—liver cancer	0.00245	0.00993	CbGpPWpGaD
Ketorolac—PTGS2—Arachidonic acid metabolism—HPGDS—liver cancer	0.00233	0.00946	CbGpPWpGaD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—CSF2—liver cancer	0.0022	0.00893	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—GGT1—liver cancer	0.0022	0.00891	CbGpPWpGaD
Ketorolac—PTGS2—Overview of nanoparticle effects—PIK3CD—liver cancer	0.00204	0.00827	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—GPX3—liver cancer	0.00199	0.00806	CbGpPWpGaD
Ketorolac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—liver cancer	0.00182	0.00739	CbGpPWpGaD
Ketorolac—PTGS2—Arachidonic acid metabolism—GGT1—liver cancer	0.00174	0.00708	CbGpPWpGaD
Ketorolac—PTGS1—Arachidonic acid metabolism—CYP1A1—liver cancer	0.00172	0.00698	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00168	0.0068	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—NR1H4—liver cancer	0.00164	0.00663	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—GSTA3—liver cancer	0.00161	0.00652	CbGpPWpGaD
Ketorolac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—liver cancer	0.00159	0.00645	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—GPX3—liver cancer	0.00158	0.0064	CbGpPWpGaD
Ketorolac—Mebendazole—CYP1A1—liver cancer	0.00154	0.806	CrCbGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—MAPK14—liver cancer	0.00153	0.00622	CbGpPWpGaD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—liver cancer	0.0015	0.0061	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—TNF—liver cancer	0.0015	0.00607	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—GSTA4—liver cancer	0.00147	0.00596	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—liver cancer	0.00146	0.00592	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—GSTA2—liver cancer	0.00143	0.00581	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—liver cancer	0.00142	0.00578	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—GGT1—liver cancer	0.0014	0.00567	CbGpPWpGaD
Ketorolac—PTGS2—S1P1 pathway—VEGFA—liver cancer	0.00139	0.00563	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—GSTA1—liver cancer	0.00138	0.00561	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—NAT2—liver cancer	0.00137	0.00555	CbGpPWpGaD
Ketorolac—PTGS2—Arachidonic acid metabolism—CYP1A1—liver cancer	0.00136	0.00554	CbGpPWpGaD
Ketorolac—Asthenia—Sorafenib—liver cancer	0.00129	0.00172	CcSEcCtD
Ketorolac—Cardiac failure—Doxorubicin—liver cancer	0.00128	0.00171	CcSEcCtD
Ketorolac—Pruritus—Sorafenib—liver cancer	0.00127	0.00169	CcSEcCtD
Ketorolac—Blood creatinine increased—Epirubicin—liver cancer	0.00127	0.00169	CcSEcCtD
Ketorolac—Hyponatraemia—Doxorubicin—liver cancer	0.00126	0.00167	CcSEcCtD
Ketorolac—Osteoarthritis—Doxorubicin—liver cancer	0.00125	0.00167	CcSEcCtD
Ketorolac—Diplopia—Doxorubicin—liver cancer	0.00125	0.00167	CcSEcCtD
Ketorolac—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00125	0.00167	CcSEcCtD
Ketorolac—Liver function test abnormal—Epirubicin—liver cancer	0.00125	0.00166	CcSEcCtD
Ketorolac—Abdominal pain upper—Epirubicin—liver cancer	0.00124	0.00165	CcSEcCtD
Ketorolac—Migraine—Doxorubicin—liver cancer	0.00123	0.00164	CcSEcCtD
Ketorolac—Hypokalaemia—Epirubicin—liver cancer	0.00123	0.00164	CcSEcCtD
Ketorolac—Diarrhoea—Sorafenib—liver cancer	0.00123	0.00164	CcSEcCtD
Ketorolac—Breast disorder—Epirubicin—liver cancer	0.00122	0.00163	CcSEcCtD
Ketorolac—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00122	0.00162	CcSEcCtD
Ketorolac—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00122	0.00162	CcSEcCtD
Ketorolac—Nasopharyngitis—Epirubicin—liver cancer	0.00121	0.00161	CcSEcCtD
Ketorolac—Face oedema—Doxorubicin—liver cancer	0.00121	0.00161	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—ESR1—liver cancer	0.00121	0.00491	CbGpPWpGaD
Ketorolac—PTGS1—Overview of nanoparticle effects—IL6—liver cancer	0.00121	0.0049	CbGpPWpGaD
Ketorolac—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.0012	0.00489	CbGpPWpGaD
Ketorolac—Gastritis—Epirubicin—liver cancer	0.0012	0.00159	CcSEcCtD
Ketorolac—Dizziness—Sorafenib—liver cancer	0.00119	0.00158	CcSEcCtD
Ketorolac—PTGS2—Overview of nanoparticle effects—TNF—liver cancer	0.00119	0.00482	CbGpPWpGaD
Ketorolac—Abdominal distension—Epirubicin—liver cancer	0.00118	0.00157	CcSEcCtD
Ketorolac—Blood creatinine increased—Doxorubicin—liver cancer	0.00117	0.00156	CcSEcCtD
Ketorolac—Asthma—Epirubicin—liver cancer	0.00117	0.00156	CcSEcCtD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—liver cancer	0.00116	0.00472	CbGpPWpGaD
Ketorolac—Eosinophilia—Epirubicin—liver cancer	0.00116	0.00154	CcSEcCtD
Ketorolac—Liver function test abnormal—Doxorubicin—liver cancer	0.00116	0.00154	CcSEcCtD
Ketorolac—Pancreatitis—Epirubicin—liver cancer	0.00115	0.00153	CcSEcCtD
Ketorolac—Vomiting—Sorafenib—liver cancer	0.00114	0.00152	CcSEcCtD
Ketorolac—Abdominal pain upper—Doxorubicin—liver cancer	0.00114	0.00152	CcSEcCtD
Ketorolac—Hypokalaemia—Doxorubicin—liver cancer	0.00114	0.00152	CcSEcCtD
Ketorolac—Rash—Sorafenib—liver cancer	0.00114	0.00151	CcSEcCtD
Ketorolac—Dermatitis—Sorafenib—liver cancer	0.00113	0.00151	CcSEcCtD
Ketorolac—Breast disorder—Doxorubicin—liver cancer	0.00113	0.00151	CcSEcCtD
Ketorolac—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—liver cancer	0.00113	0.00459	CbGpPWpGaD
Ketorolac—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00113	0.0015	CcSEcCtD
Ketorolac—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00113	0.0015	CcSEcCtD
Ketorolac—Headache—Sorafenib—liver cancer	0.00113	0.0015	CcSEcCtD
Ketorolac—Nasopharyngitis—Doxorubicin—liver cancer	0.00112	0.00149	CcSEcCtD
Ketorolac—Pancytopenia—Epirubicin—liver cancer	0.00111	0.00148	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—GGT1—liver cancer	0.00111	0.0045	CbGpPWpGaD
Ketorolac—Gastritis—Doxorubicin—liver cancer	0.00111	0.00148	CcSEcCtD
Ketorolac—Dysuria—Epirubicin—liver cancer	0.00109	0.00146	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—HPGDS—liver cancer	0.00109	0.00443	CbGpPWpGaD
Ketorolac—Abdominal distension—Doxorubicin—liver cancer	0.00109	0.00145	CcSEcCtD
Ketorolac—Asthma—Doxorubicin—liver cancer	0.00108	0.00144	CcSEcCtD
Ketorolac—Pollakiuria—Epirubicin—liver cancer	0.00108	0.00144	CcSEcCtD
Ketorolac—Eosinophilia—Doxorubicin—liver cancer	0.00107	0.00143	CcSEcCtD
Ketorolac—Nausea—Sorafenib—liver cancer	0.00107	0.00142	CcSEcCtD
Ketorolac—Photosensitivity reaction—Epirubicin—liver cancer	0.00107	0.00142	CcSEcCtD
Ketorolac—Weight increased—Epirubicin—liver cancer	0.00106	0.00142	CcSEcCtD
Ketorolac—Pancreatitis—Doxorubicin—liver cancer	0.00106	0.00141	CcSEcCtD
Ketorolac—Hyperglycaemia—Epirubicin—liver cancer	0.00106	0.0014	CcSEcCtD
Ketorolac—Pneumonia—Epirubicin—liver cancer	0.00105	0.0014	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.00105	0.00424	CbGpPWpGaD
Ketorolac—Drowsiness—Epirubicin—liver cancer	0.00104	0.00139	CcSEcCtD
Ketorolac—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00103	0.00138	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—liver cancer	0.00103	0.00419	CbGpPWpGaD
Ketorolac—Pancytopenia—Doxorubicin—liver cancer	0.00103	0.00137	CcSEcCtD
Ketorolac—Renal failure—Epirubicin—liver cancer	0.00103	0.00136	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—MTHFR—liver cancer	0.00102	0.00414	CbGpPWpGaD
Ketorolac—Stomatitis—Epirubicin—liver cancer	0.00102	0.00135	CcSEcCtD
Ketorolac—Jaundice—Epirubicin—liver cancer	0.00102	0.00135	CcSEcCtD
Ketorolac—Conjunctivitis—Epirubicin—liver cancer	0.00101	0.00135	CcSEcCtD
Ketorolac—Dysuria—Doxorubicin—liver cancer	0.00101	0.00135	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00101	0.0041	CbGpPWpGaD
Ketorolac—Sweating—Epirubicin—liver cancer	0.001	0.00133	CcSEcCtD
Ketorolac—Pollakiuria—Doxorubicin—liver cancer	0.001	0.00133	CcSEcCtD
Ketorolac—Haematuria—Epirubicin—liver cancer	0.000995	0.00132	CcSEcCtD
Ketorolac—Photosensitivity reaction—Doxorubicin—liver cancer	0.000988	0.00131	CcSEcCtD
Ketorolac—Hepatobiliary disease—Epirubicin—liver cancer	0.000987	0.00131	CcSEcCtD
Ketorolac—Weight increased—Doxorubicin—liver cancer	0.000985	0.00131	CcSEcCtD
Ketorolac—Epistaxis—Epirubicin—liver cancer	0.000984	0.00131	CcSEcCtD
Ketorolac—Hyperglycaemia—Doxorubicin—liver cancer	0.000977	0.0013	CcSEcCtD
Ketorolac—Agranulocytosis—Epirubicin—liver cancer	0.000974	0.0013	CcSEcCtD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—liver cancer	0.000974	0.00395	CbGpPWpGaD
Ketorolac—Pneumonia—Doxorubicin—liver cancer	0.000971	0.00129	CcSEcCtD
Ketorolac—Drowsiness—Doxorubicin—liver cancer	0.000965	0.00128	CcSEcCtD
Ketorolac—PTGS2—Overview of nanoparticle effects—IL6—liver cancer	0.000959	0.00389	CbGpPWpGaD
Ketorolac—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000957	0.00127	CcSEcCtD
Ketorolac—Bradycardia—Epirubicin—liver cancer	0.000954	0.00127	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—GSTM1—liver cancer	0.000951	0.00386	CbGpPWpGaD
Ketorolac—Renal failure—Doxorubicin—liver cancer	0.000949	0.00126	CcSEcCtD
Ketorolac—Haemoglobin—Epirubicin—liver cancer	0.000941	0.00125	CcSEcCtD
Ketorolac—Stomatitis—Doxorubicin—liver cancer	0.000941	0.00125	CcSEcCtD
Ketorolac—Jaundice—Doxorubicin—liver cancer	0.000941	0.00125	CcSEcCtD
Ketorolac—Rhinitis—Epirubicin—liver cancer	0.000939	0.00125	CcSEcCtD
Ketorolac—Conjunctivitis—Doxorubicin—liver cancer	0.000938	0.00125	CcSEcCtD
Ketorolac—Haemorrhage—Epirubicin—liver cancer	0.000937	0.00125	CcSEcCtD
Ketorolac—Hepatitis—Epirubicin—liver cancer	0.000937	0.00125	CcSEcCtD
Ketorolac—Sweating—Doxorubicin—liver cancer	0.000926	0.00123	CcSEcCtD
Ketorolac—Urinary tract disorder—Epirubicin—liver cancer	0.000925	0.00123	CcSEcCtD
Ketorolac—Haematuria—Doxorubicin—liver cancer	0.00092	0.00122	CcSEcCtD
Ketorolac—Connective tissue disorder—Epirubicin—liver cancer	0.00092	0.00122	CcSEcCtD
Ketorolac—Urethral disorder—Epirubicin—liver cancer	0.000918	0.00122	CcSEcCtD
Ketorolac—Hepatobiliary disease—Doxorubicin—liver cancer	0.000913	0.00121	CcSEcCtD
Ketorolac—Epistaxis—Doxorubicin—liver cancer	0.000911	0.00121	CcSEcCtD
Ketorolac—Visual impairment—Epirubicin—liver cancer	0.000903	0.0012	CcSEcCtD
Ketorolac—Agranulocytosis—Doxorubicin—liver cancer	0.000901	0.0012	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—RAF1—liver cancer	0.000897	0.00364	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—F2—liver cancer	0.000895	0.00363	CbGpPWpGaD
Ketorolac—PTGS1—Biological oxidations—CYP2E1—liver cancer	0.000891	0.00361	CbGpPWpGaD
Ketorolac—Erythema multiforme—Epirubicin—liver cancer	0.000886	0.00118	CcSEcCtD
Ketorolac—Bradycardia—Doxorubicin—liver cancer	0.000882	0.00117	CcSEcCtD
Ketorolac—Eye disorder—Epirubicin—liver cancer	0.000875	0.00116	CcSEcCtD
Ketorolac—Tinnitus—Epirubicin—liver cancer	0.000873	0.00116	CcSEcCtD
Ketorolac—Haemoglobin—Doxorubicin—liver cancer	0.000871	0.00116	CcSEcCtD
Ketorolac—Cardiac disorder—Epirubicin—liver cancer	0.000869	0.00116	CcSEcCtD
Ketorolac—Flushing—Epirubicin—liver cancer	0.000869	0.00116	CcSEcCtD
Ketorolac—Rhinitis—Doxorubicin—liver cancer	0.000869	0.00116	CcSEcCtD
Ketorolac—Haemorrhage—Doxorubicin—liver cancer	0.000867	0.00115	CcSEcCtD
Ketorolac—Hepatitis—Doxorubicin—liver cancer	0.000867	0.00115	CcSEcCtD
Ketorolac—Urinary tract disorder—Doxorubicin—liver cancer	0.000856	0.00114	CcSEcCtD
Ketorolac—Connective tissue disorder—Doxorubicin—liver cancer	0.000852	0.00113	CcSEcCtD
Ketorolac—Angiopathy—Epirubicin—liver cancer	0.00085	0.00113	CcSEcCtD
Ketorolac—Urethral disorder—Doxorubicin—liver cancer	0.00085	0.00113	CcSEcCtD
Ketorolac—Immune system disorder—Epirubicin—liver cancer	0.000846	0.00113	CcSEcCtD
Ketorolac—Mediastinal disorder—Epirubicin—liver cancer	0.000844	0.00112	CcSEcCtD
Ketorolac—Chills—Epirubicin—liver cancer	0.00084	0.00112	CcSEcCtD
Ketorolac—Arrhythmia—Epirubicin—liver cancer	0.000837	0.00111	CcSEcCtD
Ketorolac—Visual impairment—Doxorubicin—liver cancer	0.000835	0.00111	CcSEcCtD
Ketorolac—Alopecia—Epirubicin—liver cancer	0.000828	0.0011	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—CDKN1B—liver cancer	0.000822	0.00333	CbGpPWpGaD
Ketorolac—Mental disorder—Epirubicin—liver cancer	0.000821	0.00109	CcSEcCtD
Ketorolac—Erythema multiforme—Doxorubicin—liver cancer	0.000819	0.00109	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—GGT1—liver cancer	0.000818	0.00332	CbGpPWpGaD
Ketorolac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—liver cancer	0.000817	0.00331	CbGpPWpGaD
Ketorolac—Erythema—Epirubicin—liver cancer	0.000815	0.00108	CcSEcCtD
Ketorolac—Malnutrition—Epirubicin—liver cancer	0.000815	0.00108	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.000813	0.0033	CbGpPWpGaD
Ketorolac—Eye disorder—Doxorubicin—liver cancer	0.00081	0.00108	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—MTHFR—liver cancer	0.00081	0.00328	CbGpPWpGaD
Ketorolac—Tinnitus—Doxorubicin—liver cancer	0.000808	0.00108	CcSEcCtD
Ketorolac—Cardiac disorder—Doxorubicin—liver cancer	0.000804	0.00107	CcSEcCtD
Ketorolac—Flushing—Doxorubicin—liver cancer	0.000804	0.00107	CcSEcCtD
Ketorolac—Flatulence—Epirubicin—liver cancer	0.000803	0.00107	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000802	0.00325	CbGpPWpGaD
Ketorolac—Tension—Epirubicin—liver cancer	0.0008	0.00106	CcSEcCtD
Ketorolac—Dysgeusia—Epirubicin—liver cancer	0.000798	0.00106	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.000798	0.00324	CbGpPWpGaD
Ketorolac—Nervousness—Epirubicin—liver cancer	0.000792	0.00105	CcSEcCtD
Ketorolac—Back pain—Epirubicin—liver cancer	0.000789	0.00105	CcSEcCtD
Ketorolac—Angiopathy—Doxorubicin—liver cancer	0.000786	0.00105	CcSEcCtD
Ketorolac—Immune system disorder—Doxorubicin—liver cancer	0.000783	0.00104	CcSEcCtD
Ketorolac—Mediastinal disorder—Doxorubicin—liver cancer	0.000781	0.00104	CcSEcCtD
Ketorolac—Chills—Doxorubicin—liver cancer	0.000778	0.00103	CcSEcCtD
Ketorolac—Arrhythmia—Doxorubicin—liver cancer	0.000774	0.00103	CcSEcCtD
Ketorolac—Vision blurred—Epirubicin—liver cancer	0.000768	0.00102	CcSEcCtD
Ketorolac—Alopecia—Doxorubicin—liver cancer	0.000766	0.00102	CcSEcCtD
Ketorolac—Mental disorder—Doxorubicin—liver cancer	0.000759	0.00101	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—liver cancer	0.000758	0.00308	CbGpPWpGaD
Ketorolac—Ill-defined disorder—Epirubicin—liver cancer	0.000757	0.00101	CcSEcCtD
Ketorolac—Malnutrition—Doxorubicin—liver cancer	0.000754	0.001	CcSEcCtD
Ketorolac—Erythema—Doxorubicin—liver cancer	0.000754	0.001	CcSEcCtD
Ketorolac—Anaemia—Epirubicin—liver cancer	0.000754	0.001	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—liver cancer	0.000753	0.00306	CbGpPWpGaD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—liver cancer	0.000752	0.00305	CbGpPWpGaD
Ketorolac—Agitation—Epirubicin—liver cancer	0.000749	0.000997	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—SERPINE1—liver cancer	0.000745	0.00302	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—ALB—liver cancer	0.000744	0.00302	CbGpPWpGaD
Ketorolac—Flatulence—Doxorubicin—liver cancer	0.000743	0.000989	CcSEcCtD
Ketorolac—Tension—Doxorubicin—liver cancer	0.00074	0.000985	CcSEcCtD
Ketorolac—Dysgeusia—Doxorubicin—liver cancer	0.000739	0.000983	CcSEcCtD
Ketorolac—Malaise—Epirubicin—liver cancer	0.000735	0.000978	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—GSTP1—liver cancer	0.000735	0.00298	CbGpPWpGaD
Ketorolac—Nervousness—Doxorubicin—liver cancer	0.000733	0.000975	CcSEcCtD
Ketorolac—Vertigo—Epirubicin—liver cancer	0.000733	0.000975	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—liver cancer	0.000732	0.00297	CbGpPWpGaD
Ketorolac—Syncope—Epirubicin—liver cancer	0.000731	0.000973	CcSEcCtD
Ketorolac—Leukopenia—Epirubicin—liver cancer	0.00073	0.000971	CcSEcCtD
Ketorolac—Back pain—Doxorubicin—liver cancer	0.00073	0.000971	CcSEcCtD
Ketorolac—Palpitations—Epirubicin—liver cancer	0.000721	0.000959	CcSEcCtD
Ketorolac—Loss of consciousness—Epirubicin—liver cancer	0.000717	0.000953	CcSEcCtD
Ketorolac—Cough—Epirubicin—liver cancer	0.000712	0.000947	CcSEcCtD
Ketorolac—Vision blurred—Doxorubicin—liver cancer	0.000711	0.000946	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—F2—liver cancer	0.000711	0.00288	CbGpPWpGaD
Ketorolac—Convulsion—Epirubicin—liver cancer	0.000706	0.00094	CcSEcCtD
Ketorolac—PTGS2—Disease—APCS—liver cancer	0.000704	0.00286	CbGpPWpGaD
Ketorolac—Hypertension—Epirubicin—liver cancer	0.000704	0.000937	CcSEcCtD
Ketorolac—Ill-defined disorder—Doxorubicin—liver cancer	0.0007	0.000931	CcSEcCtD
Ketorolac—Anaemia—Doxorubicin—liver cancer	0.000697	0.000928	CcSEcCtD
Ketorolac—Arthralgia—Epirubicin—liver cancer	0.000694	0.000924	CcSEcCtD
Ketorolac—Chest pain—Epirubicin—liver cancer	0.000694	0.000924	CcSEcCtD
Ketorolac—Myalgia—Epirubicin—liver cancer	0.000694	0.000924	CcSEcCtD
Ketorolac—Agitation—Doxorubicin—liver cancer	0.000693	0.000922	CcSEcCtD
Ketorolac—Anxiety—Epirubicin—liver cancer	0.000692	0.00092	CcSEcCtD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000689	0.000917	CcSEcCtD
Ketorolac—Discomfort—Epirubicin—liver cancer	0.000686	0.000913	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—liver cancer	0.000683	0.00277	CbGpPWpGaD
Ketorolac—Malaise—Doxorubicin—liver cancer	0.00068	0.000905	CcSEcCtD
Ketorolac—Dry mouth—Epirubicin—liver cancer	0.000679	0.000903	CcSEcCtD
Ketorolac—Vertigo—Doxorubicin—liver cancer	0.000678	0.000902	CcSEcCtD
Ketorolac—Syncope—Doxorubicin—liver cancer	0.000677	0.0009	CcSEcCtD
Ketorolac—Leukopenia—Doxorubicin—liver cancer	0.000675	0.000898	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—GSTM1—liver cancer	0.000675	0.00274	CbGpPWpGaD
Ketorolac—Confusional state—Epirubicin—liver cancer	0.000671	0.000893	CcSEcCtD
Ketorolac—Palpitations—Doxorubicin—liver cancer	0.000667	0.000887	CcSEcCtD
Ketorolac—Anaphylactic shock—Epirubicin—liver cancer	0.000665	0.000885	CcSEcCtD
Ketorolac—Oedema—Epirubicin—liver cancer	0.000665	0.000885	CcSEcCtD
Ketorolac—Loss of consciousness—Doxorubicin—liver cancer	0.000663	0.000882	CcSEcCtD
Ketorolac—Infection—Epirubicin—liver cancer	0.000661	0.00088	CcSEcCtD
Ketorolac—Cough—Doxorubicin—liver cancer	0.000658	0.000876	CcSEcCtD
Ketorolac—Shock—Epirubicin—liver cancer	0.000655	0.000871	CcSEcCtD
Ketorolac—Convulsion—Doxorubicin—liver cancer	0.000654	0.00087	CcSEcCtD
Ketorolac—Nervous system disorder—Epirubicin—liver cancer	0.000653	0.000868	CcSEcCtD
Ketorolac—Thrombocytopenia—Epirubicin—liver cancer	0.000652	0.000867	CcSEcCtD
Ketorolac—Hypertension—Doxorubicin—liver cancer	0.000651	0.000867	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000651	0.00264	CbGpPWpGaD
Ketorolac—Tachycardia—Epirubicin—liver cancer	0.000649	0.000864	CcSEcCtD
Ketorolac—Skin disorder—Epirubicin—liver cancer	0.000646	0.00086	CcSEcCtD
Ketorolac—Hyperhidrosis—Epirubicin—liver cancer	0.000643	0.000856	CcSEcCtD
Ketorolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—liver cancer	0.000643	0.00261	CbGpPWpGaD
Ketorolac—Arthralgia—Doxorubicin—liver cancer	0.000642	0.000855	CcSEcCtD
Ketorolac—Myalgia—Doxorubicin—liver cancer	0.000642	0.000855	CcSEcCtD
Ketorolac—Chest pain—Doxorubicin—liver cancer	0.000642	0.000855	CcSEcCtD
Ketorolac—Anxiety—Doxorubicin—liver cancer	0.00064	0.000852	CcSEcCtD
Ketorolac—PTGS1—Biological oxidations—CYP1A1—liver cancer	0.00064	0.0026	CbGpPWpGaD
Ketorolac—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000638	0.000849	CcSEcCtD
Ketorolac—Discomfort—Doxorubicin—liver cancer	0.000635	0.000844	CcSEcCtD
Ketorolac—Anorexia—Epirubicin—liver cancer	0.000634	0.000844	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.000629	0.00255	CbGpPWpGaD
Ketorolac—Dry mouth—Doxorubicin—liver cancer	0.000628	0.000836	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000628	0.00255	CbGpPWpGaD
Ketorolac—Hypotension—Epirubicin—liver cancer	0.000622	0.000827	CcSEcCtD
Ketorolac—Confusional state—Doxorubicin—liver cancer	0.000621	0.000826	CcSEcCtD
Ketorolac—Anaphylactic shock—Doxorubicin—liver cancer	0.000616	0.000819	CcSEcCtD
Ketorolac—Oedema—Doxorubicin—liver cancer	0.000616	0.000819	CcSEcCtD
Ketorolac—Infection—Doxorubicin—liver cancer	0.000612	0.000814	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000606	0.000807	CcSEcCtD
Ketorolac—Shock—Doxorubicin—liver cancer	0.000606	0.000806	CcSEcCtD
Ketorolac—Nervous system disorder—Doxorubicin—liver cancer	0.000604	0.000803	CcSEcCtD
Ketorolac—Thrombocytopenia—Doxorubicin—liver cancer	0.000603	0.000802	CcSEcCtD
Ketorolac—Insomnia—Epirubicin—liver cancer	0.000602	0.000801	CcSEcCtD
Ketorolac—Tachycardia—Doxorubicin—liver cancer	0.000601	0.0008	CcSEcCtD
Ketorolac—Skin disorder—Doxorubicin—liver cancer	0.000598	0.000796	CcSEcCtD
Ketorolac—Paraesthesia—Epirubicin—liver cancer	0.000598	0.000795	CcSEcCtD
Ketorolac—Hyperhidrosis—Doxorubicin—liver cancer	0.000595	0.000792	CcSEcCtD
Ketorolac—Dyspnoea—Epirubicin—liver cancer	0.000593	0.000789	CcSEcCtD
Ketorolac—Somnolence—Epirubicin—liver cancer	0.000592	0.000787	CcSEcCtD
Ketorolac—PTGS2—Selenium Micronutrient Network—SERPINE1—liver cancer	0.000591	0.0024	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—ALB—liver cancer	0.00059	0.00239	CbGpPWpGaD
Ketorolac—Anorexia—Doxorubicin—liver cancer	0.000587	0.000781	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.000586	0.00238	CbGpPWpGaD
Ketorolac—Dyspepsia—Epirubicin—liver cancer	0.000586	0.000779	CcSEcCtD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000581	0.00236	CbGpPWpGaD
Ketorolac—Decreased appetite—Epirubicin—liver cancer	0.000578	0.00077	CcSEcCtD
Ketorolac—Hypotension—Doxorubicin—liver cancer	0.000575	0.000765	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Epirubicin—liver cancer	0.000575	0.000764	CcSEcCtD
Ketorolac—Fatigue—Epirubicin—liver cancer	0.000574	0.000763	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN2A—liver cancer	0.000573	0.00233	CbGpPWpGaD
Ketorolac—Constipation—Epirubicin—liver cancer	0.000569	0.000757	CcSEcCtD
Ketorolac—Pain—Epirubicin—liver cancer	0.000569	0.000757	CcSEcCtD
Ketorolac—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000561	0.000746	CcSEcCtD
Ketorolac—Insomnia—Doxorubicin—liver cancer	0.000557	0.000741	CcSEcCtD
Ketorolac—Paraesthesia—Doxorubicin—liver cancer	0.000553	0.000736	CcSEcCtD
Ketorolac—Dyspnoea—Doxorubicin—liver cancer	0.000549	0.00073	CcSEcCtD
Ketorolac—Feeling abnormal—Epirubicin—liver cancer	0.000548	0.00073	CcSEcCtD
Ketorolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—liver cancer	0.000548	0.00222	CbGpPWpGaD
Ketorolac—Somnolence—Doxorubicin—liver cancer	0.000547	0.000728	CcSEcCtD
Ketorolac—Gastrointestinal pain—Epirubicin—liver cancer	0.000544	0.000724	CcSEcCtD
Ketorolac—Dyspepsia—Doxorubicin—liver cancer	0.000542	0.000721	CcSEcCtD
Ketorolac—Decreased appetite—Doxorubicin—liver cancer	0.000535	0.000712	CcSEcCtD
Ketorolac—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000532	0.000707	CcSEcCtD
Ketorolac—Fatigue—Doxorubicin—liver cancer	0.000531	0.000706	CcSEcCtD
Ketorolac—Urticaria—Epirubicin—liver cancer	0.000529	0.000703	CcSEcCtD
Ketorolac—Constipation—Doxorubicin—liver cancer	0.000527	0.000701	CcSEcCtD
Ketorolac—Pain—Doxorubicin—liver cancer	0.000527	0.000701	CcSEcCtD
Ketorolac—Body temperature increased—Epirubicin—liver cancer	0.000526	0.0007	CcSEcCtD
Ketorolac—Abdominal pain—Epirubicin—liver cancer	0.000526	0.0007	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.000524	0.00213	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000517	0.0021	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN1B—liver cancer	0.000508	0.00206	CbGpPWpGaD
Ketorolac—Feeling abnormal—Doxorubicin—liver cancer	0.000507	0.000675	CcSEcCtD
Ketorolac—Gastrointestinal pain—Doxorubicin—liver cancer	0.000503	0.00067	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000498	0.00202	CbGpPWpGaD
Ketorolac—PTGS2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000494	0.002	CbGpPWpGaD
Ketorolac—Hypersensitivity—Epirubicin—liver cancer	0.00049	0.000652	CcSEcCtD
Ketorolac—Urticaria—Doxorubicin—liver cancer	0.000489	0.000651	CcSEcCtD
Ketorolac—Abdominal pain—Doxorubicin—liver cancer	0.000487	0.000648	CcSEcCtD
Ketorolac—Body temperature increased—Doxorubicin—liver cancer	0.000487	0.000648	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CCND1—liver cancer	0.000484	0.00196	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00048	0.00195	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—UGDH—liver cancer	0.000479	0.00194	CbGpPWpGaD
Ketorolac—Asthenia—Epirubicin—liver cancer	0.000477	0.000635	CcSEcCtD
Ketorolac—Pruritus—Epirubicin—liver cancer	0.000471	0.000626	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—CDKN1A—liver cancer	0.000468	0.0019	CbGpPWpGaD
Ketorolac—Diarrhoea—Epirubicin—liver cancer	0.000455	0.000606	CcSEcCtD
Ketorolac—Hypersensitivity—Doxorubicin—liver cancer	0.000454	0.000604	CcSEcCtD
Ketorolac—PTGS1—Metabolism—EPT1—liver cancer	0.00045	0.00183	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.00045	0.00182	CbGpPWpGaD
Ketorolac—Asthenia—Doxorubicin—liver cancer	0.000442	0.000588	CcSEcCtD
Ketorolac—Dizziness—Epirubicin—liver cancer	0.00044	0.000585	CcSEcCtD
Ketorolac—PTGS1—Selenium Micronutrient Network—TNF—liver cancer	0.000439	0.00178	CbGpPWpGaD
Ketorolac—Pruritus—Doxorubicin—liver cancer	0.000436	0.00058	CcSEcCtD
Ketorolac—PTGS1—Metabolism—TAT—liver cancer	0.000427	0.00173	CbGpPWpGaD
Ketorolac—Vomiting—Epirubicin—liver cancer	0.000423	0.000563	CcSEcCtD
Ketorolac—Diarrhoea—Doxorubicin—liver cancer	0.000421	0.000561	CcSEcCtD
Ketorolac—Rash—Epirubicin—liver cancer	0.00042	0.000558	CcSEcCtD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00042	0.0017	CbGpPWpGaD
Ketorolac—Dermatitis—Epirubicin—liver cancer	0.000419	0.000558	CcSEcCtD
Ketorolac—Headache—Epirubicin—liver cancer	0.000417	0.000555	CcSEcCtD
Ketorolac—Dizziness—Doxorubicin—liver cancer	0.000407	0.000542	CcSEcCtD
Ketorolac—Nausea—Epirubicin—liver cancer	0.000395	0.000526	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000395	0.0016	CbGpPWpGaD
Ketorolac—Vomiting—Doxorubicin—liver cancer	0.000391	0.000521	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—MYC—liver cancer	0.000388	0.00158	CbGpPWpGaD
Ketorolac—Rash—Doxorubicin—liver cancer	0.000388	0.000517	CcSEcCtD
Ketorolac—Dermatitis—Doxorubicin—liver cancer	0.000388	0.000516	CcSEcCtD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000387	0.00157	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—CDKN1B—liver cancer	0.000387	0.00157	CbGpPWpGaD
Ketorolac—Headache—Doxorubicin—liver cancer	0.000386	0.000513	CcSEcCtD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000381	0.00155	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—UGDH—liver cancer	0.00038	0.00154	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—CASP3—liver cancer	0.000379	0.00154	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL2—liver cancer	0.000379	0.00154	CbGpPWpGaD
Ketorolac—Ketoprofen—ALB—liver cancer	0.000371	0.194	CrCbGaD
Ketorolac—PTGS2—Spinal Cord Injury—CCND1—liver cancer	0.000369	0.0015	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000366	0.00148	CbGpPWpGaD
Ketorolac—Nausea—Doxorubicin—liver cancer	0.000366	0.000487	CcSEcCtD
Ketorolac—PTGS2—C-MYB transcription factor network—KRAS—liver cancer	0.000359	0.00146	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MMP9—liver cancer	0.000358	0.00145	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—EPT1—liver cancer	0.000357	0.00145	CbGpPWpGaD
Ketorolac—PTGS1—Selenium Micronutrient Network—IL6—liver cancer	0.000354	0.00144	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—TNF—liver cancer	0.000349	0.00141	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—TAT—liver cancer	0.000339	0.00137	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000333	0.00135	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000314	0.00127	CbGpPWpGaD
Ketorolac—PTGS2—C-MYB transcription factor network—HRAS—liver cancer	0.000305	0.00124	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—MYC—liver cancer	0.000296	0.0012	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TGFB1—liver cancer	0.000295	0.0012	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GLUL—liver cancer	0.00029	0.00118	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CPT1B—liver cancer	0.00029	0.00118	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000287	0.00117	CbGpPWpGaD
Ketorolac—PTGS2—Selenium Micronutrient Network—IL6—liver cancer	0.000281	0.00114	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NR1H4—liver cancer	0.00028	0.00113	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TNF—liver cancer	0.000276	0.00112	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTA3—liver cancer	0.000275	0.00112	CbGpPWpGaD
Ketorolac—PTGS2—Disease—LTF—liver cancer	0.000275	0.00112	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000263	0.00107	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000258	0.00105	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTA4—liver cancer	0.000251	0.00102	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.000251	0.00102	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.00025	0.00102	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000249	0.00101	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000249	0.00101	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000246	0.000997	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTA2—liver cancer	0.000245	0.000994	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—TP53—liver cancer	0.000243	0.000986	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000243	0.000985	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000237	0.000962	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTA1—liver cancer	0.000236	0.000959	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—NAT2—liver cancer	0.000234	0.000948	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CPT1B—liver cancer	0.00023	0.000934	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GLUL—liver cancer	0.00023	0.000934	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000225	0.000912	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALDOB—liver cancer	0.000224	0.000909	CbGpPWpGaD
Ketorolac—PTGS2—Spinal Cord Injury—IL6—liver cancer	0.000222	0.000903	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NR1H4—liver cancer	0.000222	0.000901	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.000219	0.000888	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTA3—liver cancer	0.000218	0.000885	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CRABP1—liver cancer	0.000214	0.000867	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ALDOB—liver cancer	0.000212	0.000862	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000201	0.000817	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000201	0.000815	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTA4—liver cancer	0.0002	0.00081	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000195	0.000791	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTA2—liver cancer	0.000195	0.000789	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000192	0.000781	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTA1—liver cancer	0.000188	0.000761	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000188	0.000761	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HPGDS—liver cancer	0.000187	0.000758	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.000186	0.000755	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000186	0.000754	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—NAT2—liver cancer	0.000186	0.000753	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000178	0.000724	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALDOB—liver cancer	0.000178	0.000722	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000171	0.000693	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CRABP1—liver cancer	0.00017	0.000689	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000169	0.000686	CbGpPWpGaD
Ketorolac—PTGS2—Disease—ADAM17—liver cancer	0.000168	0.000681	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000167	0.000678	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PSMD10—liver cancer	0.000167	0.000676	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PSMA4—liver cancer	0.000167	0.000676	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000165	0.000671	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GOT2—liver cancer	0.000162	0.000657	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PSMD10—liver cancer	0.000158	0.00064	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PSMA4—liver cancer	0.000158	0.00064	CbGpPWpGaD
Ketorolac—PTGS2—Disease—GOT2—liver cancer	0.000154	0.000623	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000153	0.00062	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP2E1—liver cancer	0.000152	0.000618	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HPGDS—liver cancer	0.000148	0.000602	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000147	0.000598	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000147	0.000598	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYCS—liver cancer	0.000143	0.000578	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GGT1—liver cancer	0.00014	0.000567	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GOT1—liver cancer	0.00014	0.000567	CbGpPWpGaD
Ketorolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.00014	0.000566	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000134	0.000545	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000133	0.000538	CbGpPWpGaD
Ketorolac—PTGS2—Disease—GOT1—liver cancer	0.000133	0.000538	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PSMA4—liver cancer	0.000132	0.000536	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PSMD10—liver cancer	0.000132	0.000536	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GOT2—liver cancer	0.000129	0.000522	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTP1—liver cancer	0.000126	0.00051	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—HMOX1—liver cancer	0.000124	0.000503	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PRKCE—liver cancer	0.000122	0.000496	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP2E1—liver cancer	0.000121	0.000491	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000117	0.000475	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—GSTM1—liver cancer	0.000115	0.000468	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYCS—liver cancer	0.000113	0.000459	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GOT1—liver cancer	0.000111	0.00045	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GGT1—liver cancer	0.000111	0.00045	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—CYP1A1—liver cancer	0.000109	0.000444	CbGpPWpGaD
Ketorolac—PTGS2—Disease—H2AFX—liver cancer	0.000107	0.000433	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—MTHFR—liver cancer	0.000102	0.000414	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PPARA—liver cancer	0.0001	0.000406	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTP1—liver cancer	9.97e-05	0.000405	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—HMOX1—liver cancer	9.84e-05	0.000399	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MTHFR—liver cancer	9.67e-05	0.000392	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TERT—liver cancer	9.64e-05	0.000391	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—GSTM1—liver cancer	9.16e-05	0.000372	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.99e-05	0.000365	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—CYP1A1—liver cancer	8.69e-05	0.000352	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CG—liver cancer	8.57e-05	0.000348	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PPARG—liver cancer	8.27e-05	0.000336	CbGpPWpGaD
Ketorolac—PTGS2—Disease—APC—liver cancer	8.13e-05	0.00033	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—MTHFR—liver cancer	8.1e-05	0.000329	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PPARA—liver cancer	7.95e-05	0.000322	CbGpPWpGaD
Ketorolac—PTGS2—Disease—BRAF—liver cancer	7.64e-05	0.00031	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CD—liver cancer	7.54e-05	0.000306	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—ALB—liver cancer	7.44e-05	0.000302	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CD—liver cancer	7.14e-05	0.00029	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	7.14e-05	0.00029	CbGpPWpGaD
Ketorolac—PTGS2—Disease—SERPINE1—liver cancer	7.06e-05	0.000287	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CG—liver cancer	6.8e-05	0.000276	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CB—liver cancer	6.57e-05	0.000266	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PPARG—liver cancer	6.57e-05	0.000266	CbGpPWpGaD
Ketorolac—PTGS2—Disease—RAF1—liver cancer	6.38e-05	0.000259	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CB—liver cancer	6.23e-05	0.000253	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MTOR—liver cancer	6.23e-05	0.000253	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CD—liver cancer	5.98e-05	0.000243	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—ALB—liver cancer	5.91e-05	0.00024	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1B—liver cancer	5.84e-05	0.000237	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CTNNB1—liver cancer	5.52e-05	0.000224	CbGpPWpGaD
Ketorolac—PTGS2—Disease—CDKN1A—liver cancer	5.39e-05	0.000219	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CB—liver cancer	5.21e-05	0.000212	CbGpPWpGaD
Ketorolac—PTGS2—Disease—STAT3—liver cancer	4.81e-05	0.000195	CbGpPWpGaD
Ketorolac—PTGS2—Disease—MYC—liver cancer	4.47e-05	0.000181	CbGpPWpGaD
Ketorolac—PTGS2—Disease—TGFB1—liver cancer	4.46e-05	0.000181	CbGpPWpGaD
Ketorolac—PTGS2—Disease—KRAS—liver cancer	4.13e-05	0.000168	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—PIK3CA—liver cancer	4e-05	0.000162	CbGpPWpGaD
Ketorolac—PTGS2—Disease—PIK3CA—liver cancer	3.8e-05	0.000154	CbGpPWpGaD
Ketorolac—PTGS2—Disease—HRAS—liver cancer	3.51e-05	0.000142	CbGpPWpGaD
Ketorolac—PTGS2—Disease—IL6—liver cancer	3.36e-05	0.000136	CbGpPWpGaD
Ketorolac—PTGS1—Metabolism—AKT1—liver cancer	3.27e-05	0.000133	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—PIK3CA—liver cancer	3.18e-05	0.000129	CbGpPWpGaD
Ketorolac—PTGS2—Disease—AKT1—liver cancer	3.1e-05	0.000126	CbGpPWpGaD
Ketorolac—PTGS2—Metabolism—AKT1—liver cancer	2.6e-05	0.000105	CbGpPWpGaD
